Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia

Chimeric antigen receptor–modified T cells with specificity for CD19 have shown promise in the treatment of chronic lymphocytic leukemia (CLL). It remains to be established whether chimeric antigen receptor T cells have clinical activity in acute lymphoblastic leukemia (ALL). Two children with relap...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Grupp, Stephan A., Kalos, Michael, Barrett, David, Aplenc, Richard, Porter, David L., Rheingold, Susan R., Teachey, David T., Chew, Anne, Hauck, Bernd, Wright, J. Fraser, Milone, Michael C., Levine, Bruce L., June, Carl H.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2013
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4058440/
https://ncbi.nlm.nih.gov/pubmed/23527958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1215134
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन